Table 1.
Patient and tumor characteristics (n = 16)
Median age (range) | 57 (40–77) years |
---|---|
Menopausal status | |
Premenopausal | 4 (25%) |
Postmenopausal | 12 (75%) |
Histology | |
Ductal | 8 (50%) |
Lobular | 8 (50%) |
Histologic grade | |
1 | 3 (19%) |
2 | 11 (69%) |
3 | 2 (12%) |
Clinical T and N stage | |
T2N0 | 6 (38%) |
T2N1 | 3 (19%) |
T3N0 | 2 (13%) |
T3N1 | 4 (25%) |
Unknown | 1 (6%) |
PIK3CA mutation | |
E542K/V | 2 (13%) |
E545K | 3 (19%) |
H1047L/R | 8 (50%) |
E418G, C420R | 1 (6%) |
Del/ins | 2 (13%) |